IRIS - Res&Arch Institutional Research Information System - Research & Archive

COSTA, CINZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.233
EU - Europa 1.921
AS - Asia 755
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 4.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.230
IE - Irlanda 506
IT - Italia 319
UA - Ucraina 304
HK - Hong Kong 292
SE - Svezia 211
FR - Francia 187
SG - Singapore 174
CN - Cina 132
VN - Vietnam 108
RU - Federazione Russa 84
DE - Germania 83
FI - Finlandia 82
GB - Regno Unito 48
RO - Romania 26
KR - Corea 21
BE - Belgio 17
CZ - Repubblica Ceca 15
CH - Svizzera 12
TR - Turchia 10
NL - Olanda 9
LB - Libano 6
EU - Europa 5
GR - Grecia 5
UZ - Uzbekistan 5
AT - Austria 4
CL - Cile 3
MX - Messico 3
AR - Argentina 2
ES - Italia 2
JP - Giappone 2
MO - Macao, regione amministrativa speciale della Cina 2
PL - Polonia 2
RS - Serbia 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
Totale 4.921
Salva come PNG Salva come JPEG
Città #
Chandler 569
Dublin 501
Hong Kong 292
San Mateo 203
Jacksonville 170
Altamura 137
Medford 111
Dong Ket 108
Princeton 108
Perugia 107
Singapore 106
Lawrence 101
Wilmington 86
Ann Arbor 82
Andover 74
Beijing 65
Boardman 57
Des Moines 51
Redmond 43
Los Angeles 23
San Paolo di Civitate 21
Seoul 21
Saint Petersburg 19
Bucharest 18
Woodbridge 18
Norwalk 17
Brussels 15
Helsinki 15
Izmir 10
Falls Church 9
Redwood City 9
Boydton 8
Moscow 8
Brno 7
Ashburn 6
Den Haag 6
London 6
Munich 6
Olomouc 5
Cava de' Tirreni 4
Falkenstein 4
Houston 4
Lappeenranta 4
Pomezia 4
Terni 4
Auburn Hills 3
Naples 3
Zhengzhou 3
Chicago 2
Hasselt 2
Jesi 2
Milan 2
Munro 2
Nagold 2
Rome 2
San Diego 2
Santiago 2
Tappahannock 2
Timisoara 2
Utrecht 2
Almaty 1
Altino 1
Amsterdam 1
Assisi 1
Bielefeld 1
Bologna 1
Cambridge 1
City Of Industry 1
Clifton 1
Dearborn 1
Derio 1
Edinburgh 1
Ferrara 1
Florence 1
Frankfurt Am Main 1
Frankfurt am Main 1
Fremont 1
Grammichele 1
Guangzhou 1
Kalngale 1
Lausanne 1
Lebrija 1
Ludwigshafen 1
Ludwigshafen am Rhein 1
Maceió 1
Mogliano 1
Monterrey 1
Paris 1
Pars 1
Prague 1
Qingdao 1
Secaucus 1
Southwell 1
Sovicille 1
Sydney 1
Tel Aviv 1
Tokyo 1
Woodford 1
Totale 3.313
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 145
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 88
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 83
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 81
Effect of psychotropic drugs on seizure threshold 81
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 81
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 78
Levetiracetam-associated hyponatremia. 77
Plasticity and repair in the post-ischemic brain 73
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 70
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series 69
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 67
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 65
Hippocampal epileptogenesis in autoimmune encephalitis 65
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 64
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 63
Occipital arteriovenous malformations andmigraine. 61
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 61
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 59
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 59
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 59
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 59
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 58
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. 56
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 56
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 55
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 53
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 52
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 52
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 52
Neural 17beta-estradiol facilitates long-term potentiation in the hippocampal CA1 region 52
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 51
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events? 51
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 51
Brain arteriovenous malformations and seizures: an Italian study. 50
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy 50
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 49
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 48
Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. 47
Cortical spreading depression as a target for anti-migraine agents. 46
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 46
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 46
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 46
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 45
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 44
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice. 44
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 44
Management of epilepsy in brain tumors 44
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 44
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. 44
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 43
Amyloid-β: a potential link between epilepsy and cognitive decline 43
Chronic cocaine prevents depotentiation at corticostriatal synapses. 41
Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity 41
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice 41
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 40
Clinical features and outcome of 6 new patients carrying de novoKCNB1gene mutations 40
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 40
Migraine and epilepsy: what value today? 40
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis 40
Dopaminergic and Behavioral Deficits Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 39
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. 39
Levetiracetam protects against kainic acid-induced toxicity. 39
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 39
null 39
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. 38
Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. 38
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 38
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. 37
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. 37
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 37
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study. 36
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 36
Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: Focus on antiepileptic drugs 36
Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid-β 36
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 36
Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina. 35
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 35
Modelli sperimentali 35
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 35
Identification of amoeba in the CSF in a patient with meningoencephalitis 34
Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study. 34
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 34
Obsessive-compulsive disorder and migraine with medication-overuse headache. 34
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na(+)/K(+) ATPase. 33
Late-onset n-acetylglutamate synthase deficiency: Report of a paradigmatic adult case presenting with headaches and review of the literature 33
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 33
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 33
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. 32
Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study 32
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 32
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 31
Rivaroxaban Plasma Levels and Levetiracetam: A Case Report 31
Cefalee e sonno 30
Rivaroxaban Plasma Levels and Levetiracetam RESPONSE 30
Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3 29
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 28
Striatum-hippocampusbalance: from physiological behavior to interneuronal pathology. 28
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice. 27
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. 26
Totale 4.757
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020477 59 10 55 5 43 43 53 47 56 62 7 37
2020/2021774 7 45 27 49 226 37 65 29 86 25 59 119
2021/2022901 15 168 30 42 33 13 13 262 19 54 124 128
2022/20231.839 118 378 33 151 166 195 0 67 660 8 46 17
2023/2024806 43 75 34 10 3 3 177 11 117 26 153 154
2024/202524 24 0 0 0 0 0 0 0 0 0 0 0
Totale 5.173